Rocket


News + Filings
Transactions



Bir Dawn Carter

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
09/26/2023REATA PHARMACEUTICALS INCRETADispositionEmployee Stock Option (right to buy)24k$207.20$5M 09/26/2023
09/26/2023REATA PHARMACEUTICALS INCRETADispositionClass A common stock33.8k$0.00$0 09/26/2023
09/26/2023REATA PHARMACEUTICALS INCRETADispositionEmployee Stock Option (right to buy)16.5k$121.29$2M 09/26/2023
09/26/2023REATA PHARMACEUTICALS INCRETADispositionEmployee Stock Option (right to buy)70k$27.32$1.9M 09/26/2023
09/26/2023REATA PHARMACEUTICALS INCRETADispositionEmployee Stock Option (right to buy)63.6k$36.71$2.3M 09/26/2023
09/26/2023REATA PHARMACEUTICALS INCRETADispositionEmployee Stock Option (right to buy)71.3k$24.75$1.8M 09/26/2023
09/26/2023REATA PHARMACEUTICALS INCRETADispositionEmployee Stock Option (right to buy)34.5k$55.73$1.9M 09/26/2023
09/26/2023REATA PHARMACEUTICALS INCRETADispositionEmployee Stock Option (right to buy)17.2k$55.73$961.3k 09/26/2023
08/16/2023REATA PHARMACEUTICALS INCRETASaleClass A common stock398$168.33$67k 08/15/2023
08/15/2023REATA PHARMACEUTICALS INCRETASaleClass A common stock807$169.04$136.4k 08/15/2023
07/06/2023REATA PHARMACEUTICALS INCRETAGrantClass A common stock4.1k$0.00$0 07/06/2023
05/31/2023GERON CORPGERNGrantStock Option (right to buy)125k$3.27$408.8k 05/31/2023
05/16/2023REATA PHARMACEUTICALS INCRETASaleClass A common stock417$80.96$33.8k 05/15/2023
05/15/2023REATA PHARMACEUTICALS INCRETASaleClass A common stock894$85.09$76.1k 05/15/2023
03/13/2023REATA PHARMACEUTICALS INCRETASaleClass A common stock9.3k$86.77$808.4k 03/13/2023
03/07/2023REATA PHARMACEUTICALS INCRETAConversionClass B common stock41.6k$0.00$0 03/06/2023
03/07/2023REATA PHARMACEUTICALS INCRETAExerciseClass B common stock41.6k$21.05$876.3k 03/06/2023
03/07/2023REATA PHARMACEUTICALS INCRETASaleClass A common stock200$86.67$17.3k 03/06/2023
03/07/2023REATA PHARMACEUTICALS INCRETASaleClass A common stock5.8k$85.90$497.6k 03/06/2023
03/07/2023REATA PHARMACEUTICALS INCRETASaleClass A common stock36k$85.08$3.1M 03/06/2023
03/07/2023REATA PHARMACEUTICALS INCRETAConversionClass A common stock41.6k$0.00$0 03/06/2023
03/06/2023REATA PHARMACEUTICALS INCRETASaleClass A common stock14.8k$90.26$1.3M 03/06/2023
03/06/2023REATA PHARMACEUTICALS INCRETASaleClass A common stock40.1k$89.30$3.6M 03/06/2023
03/06/2023REATA PHARMACEUTICALS INCRETAConversionClass A common stock48.4k$0.00$0 03/06/2023
03/06/2023REATA PHARMACEUTICALS INCRETAConversionClass B common stock48.4k$0.00$0 03/06/2023
03/06/2023REATA PHARMACEUTICALS INCRETAExerciseClass B common stock48.4k$21.05$1M 03/06/2023
03/03/2023REATA PHARMACEUTICALS INCRETASaleClass A common stock2.2k$88.25$191.1k 03/03/2023
01/03/2023REATA PHARMACEUTICALS INCRETAGrantEmployee Stock Option (right-to-buy)63.6k$36.71$2.3M 01/03/2023
01/03/2023REATA PHARMACEUTICALS INCRETAGrantClass A common stock15.7k$0.00$0 01/03/2023
05/10/2022GERON CORPGERNGrantStock Option (right to buy)125k$1.48$185k 05/10/2022
01/03/2022REATA PHARMACEUTICALS INCRETAGrantClass A common stock35k$0.00$0 01/03/2022
01/03/2022REATA PHARMACEUTICALS INCRETAGrantEmployee Stock Option (right to buy)70k$27.32$1.9M 01/03/2022
05/11/2021GERON CORPGERNGrantStock Option (right to buy)83k$1.39$115.4k 05/11/2021
11/09/2020REATA PHARMACEUTICALS INCRETAConversionClass A common stock60k$0.00$0 11/09/2020
11/09/2020REATA PHARMACEUTICALS INCRETASaleClass A common stock30k$150.01$4.5M 11/09/2020
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy